Enveric Biosciences (ENVB) stock Forecast for 2022 – 2026
Last update: March 27, 2023 (13:26)Sector: Healthcare
The share price of Enveric Biosciences, Inc. (ENVB) now
50/200 Day Moving Average: $2.427 / $4.849
This figure corresponds to the Average Price over the previous 50/200 days. For Enveric Biosciences stocks, the 50-day moving average is the resistance level today.
For Enveric Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Enveric Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Enveric Biosciences stock price in 2023, 2024, 2025, 2026, 2027. How much will one Enveric Biosciences share be worth in 2023 - 2027?
When should I take profit in Enveric Biosciences stock? When should I record a loss on Enveric Biosciences stock? What are analysts' forecasts for Enveric Biosciences stock? What is the future of Enveric Biosciences stock? We forecast Enveric Biosciences stock performance using neural networks based on historical data on Enveric Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Enveric Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Enveric Biosciences shares. This happens once a day.
Historical and forecast chart of Enveric Biosciences stock
The chart below shows the historical price of Enveric Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Enveric Biosciences stock price can be found in the table below.
Long-term forecasts by years.
Enveric Biosciences daily forecast for a month
Enveric Biosciences Daily Price Targets
Enveric Biosciences Stock Forecast 03-29-2023.
Forecast target price for 03-29-2023: $1.72.
Positive dynamics for Enveric Biosciences shares will prevail with possible volatility of 4.898%.
Pessimistic target level: 1.69
Optimistic target level: 1.77
Enveric Biosciences Stock Forecast 03-30-2023.
Forecast target price for 03-30-2023: $1.69.
Negative dynamics for Enveric Biosciences shares will prevail with possible volatility of 2.129%.
Pessimistic target level: 1.67
Optimistic target level: 1.71
Enveric Biosciences Stock Forecast 03-31-2023.
Forecast target price for 03-31-2023: $1.73.
Positive dynamics for Enveric Biosciences shares will prevail with possible volatility of 5.512%.
Pessimistic target level: 1.69
Optimistic target level: 1.79
Enveric Biosciences Stock Forecast 04-01-2023.
Forecast target price for 04-01-2023: $1.72.
Negative dynamics for Enveric Biosciences shares will prevail with possible volatility of 4.673%.
Pessimistic target level: 1.66
Optimistic target level: 1.74
Enveric Biosciences Stock Forecast 04-02-2023.
Forecast target price for 04-02-2023: $1.69.
Negative dynamics for Enveric Biosciences shares will prevail with possible volatility of 4.281%.
Pessimistic target level: 1.65
Optimistic target level: 1.72
Enveric Biosciences Stock Forecast 04-03-2023.
Forecast target price for 04-03-2023: $1.74.
Positive dynamics for Enveric Biosciences shares will prevail with possible volatility of 5.902%.
Pessimistic target level: 1.69
Optimistic target level: 1.80
ENVB (ENVB) Monthly Stock Prediction for 2023
Enveric Biosciences forecast for this year
Enveric Biosciences Stock Prediction for Apr 2023
An uptrend is forecast for this month with an optimal target price of $1.91822. Pessimistic: $1.65. Optimistic: $2.04
Enveric Biosciences Stock Prediction for May 2023
An uptrend is forecast for this month with an optimal target price of $2.05633. Pessimistic: $1.70. Optimistic: $2.39
Enveric Biosciences Stock Prediction for Jun 2023
An uptrend is forecast for this month with an optimal target price of $2.32776. Pessimistic: $1.82. Optimistic: $2.53
Enveric Biosciences Stock Prediction for Jul 2023
An uptrend is forecast for this month with an optimal target price of $2.43949. Pessimistic: $1.93. Optimistic: $2.86
Enveric Biosciences Stock Prediction for Aug 2023
An downtrend is forecast for this month with an optimal target price of $1.78815. Pessimistic: $1.61. Optimistic: $2.09
Enveric Biosciences Stock Prediction for Sep 2023
An downtrend is forecast for this month with an optimal target price of $1.64867. Pessimistic: $1.25. Optimistic: $1.78
Enveric Biosciences Stock Prediction for Oct 2023
An uptrend is forecast for this month with an optimal target price of $1.97511. Pessimistic: $1.76. Optimistic: $2.26
Enveric Biosciences Stock Prediction for Nov 2023
An uptrend is forecast for this month with an optimal target price of $1.99881. Pessimistic: $1.57. Optimistic: $2.38
Enveric Biosciences Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $2.23267. Pessimistic: $1.76. Optimistic: $2.57
Enveric Biosciences (ENVB) Monthly Stock Prediction for 2024
Enveric Biosciences (ENVB) Monthly Stock Prediction for 2025
Enveric Biosciences (ENVB) Monthly Stock Prediction for 2026
Enveric Biosciences (ENVB) Monthly Stock Prediction for 2027
Enveric Biosciences information and performance
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.
2025 GATEWAY PLACE, SUITE 365, SAN JOSE, CA, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Enveric Biosciences (ENVB) stock dividend
Enveric Biosciences last paid dividends on 04/23/2008. The next scheduled payment will be on 11/25/2019. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.